OVID THERAPEUTICS INC (OVID)       1.74  -0.01 (-0.57%)

1.74  -0.01 (-0.57%)

US6904691010 - Common Stock - After market: 1.65 -0.09 (-5.17%)

Buy % Consensus

Analysts have set a mean price target of 5.61. This target is 222.41% above the current price.
OVID was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OVID.
In the previous month the buy percentage consensus was at a similar level.
OVID was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 1.744.045.615.617.35 - 132.18% 222.41% 222.41% 322.41%

Up and Down Grades

Date Firm Action Rating
2022-05-20 Citigroup Maintains Neutral
2021-08-25 Citigroup Maintains Neutral
2021-04-20 Cantor Fitzgerald Downgrade Overweight -> Neutral

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA